Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001062993-25-004815

Chief Commercial Ofc Imm Med sold 44,665 shares at an average $6.98 ($311,792)

  • Chief Commercial Ofc Imm Med acquired 109,973 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

BENZENO SHARON · Chief Commercial Ofc Imm Med

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2025-03-04 Grant or award : show line 1 in the form +109,973 437,388 D
2025-03-05 Sale : show line 2 in the form −41,600 $6.98 $290,368 395,788 D
2025-03-05 Sale : show line 3 in the form −3,065 $6.99 $21,424 392,723 D
Open-market sales · 44,665 sh · avg $6.98 · $311,792

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-03-04 Grant or award : show line 4 in the form Stock Option (right to buy) +165,027 165,027 D
Loading xslF345X05/form4.xml…